PIII - P3 Health sees 2023 revenue below Wall Street estimates
- P3 Health Partners ( NASDAQ: PIII ) on Wednesday forecast 2023 revenue below street estimates.
- The company expects revenue to be in a range of $1.20B to $1.25B, below estimates of $1.37B.
- For 2023, Medicare Advantage membership is expected to be in a range of 115,000 to 120,000.
- The company expects that 2023 Adjusted EBITDA loss will be between $40M and $60M and anticipates adjusted EBITDA to be positive in 2024.
- P3 also reaffirmed 2022 revenue guidance range given of between $1.025B and $1.075B vs $1.05B consensus, representing a 61% to 69% increase over 2021.
- The at-risk Medicare Advantage membership is still expected to be greater than 100,000 for the full-year 2022.
For further details see:
P3 Health sees 2023 revenue below Wall Street estimates